May 10, 2024

Maze Therapeutics

Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease

May 09, 2024

Seaport Therapeutics

Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

May 08, 2024

Tango Therapeutics

Tango Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

May 07, 2024


ARTBIO and Nucleus RadioPharma Announce Collaboration to Manufacture GMP-Grade Therapeutic Products Containing Radioisotope Pb-212 to Support Emerging Clinical Trials

May 07, 2024

Pliant Therapeutics

Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™

Load More

Sign up for weekly portfolio news.